The future of MDR protein research lies in understanding the complex mechanisms that regulate their expression and function. Advances in genomics and proteomics can help identify novel targets for therapeutic intervention. Additionally, personalized medicine approaches that tailor treatment based on the specific MDR profile of a patient's tumor may offer new hope for overcoming drug resistance in cancer.